These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
568 related items for PubMed ID: 24931591
1. Sleeping in moderate hypoxia at home for prevention of acute mountain sickness (AMS): a placebo-controlled, randomized double-blind study. Dehnert C, Böhm A, Grigoriev I, Menold E, Bärtsch P. Wilderness Environ Med; 2014 Sep; 25(3):263-71. PubMed ID: 24931591 [Abstract] [Full Text] [Related]
2. Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID). Lipman GS, Kanaan NC, Phillips C, Pomeranz D, Cain P, Fontes K, Higbee B, Meyer C, Shaheen M, Wentworth S, Walsh D. High Alt Med Biol; 2015 Jun; 16(2):154-61. PubMed ID: 25950723 [Abstract] [Full Text] [Related]
3. Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m. Schommer K, Wiesegart N, Menold E, Haas U, Lahr K, Buhl H, Bärtsch P, Dehnert C. High Alt Med Biol; 2010 Jun; 11(1):19-25. PubMed ID: 20367484 [Abstract] [Full Text] [Related]
4. Acute mountain sickness is not repeatable across two 12-hour normobaric hypoxia exposures. MacInnis MJ, Koch S, MacLeod KE, Carter EA, Jain R, Koehle MS, Rupert JL. Wilderness Environ Med; 2014 Jun; 25(2):143-51. PubMed ID: 24631230 [Abstract] [Full Text] [Related]
5. Effect of repeated normobaric hypoxia exposures during sleep on acute mountain sickness, exercise performance, and sleep during exposure to terrestrial altitude. Fulco CS, Muza SR, Beidleman BA, Demes R, Staab JE, Jones JE, Cymerman A. Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R428-36. PubMed ID: 21123763 [Abstract] [Full Text] [Related]
6. Low-dose theophylline reduces symptoms of acute mountain sickness. Küpper TE, Strohl KP, Hoefer M, Gieseler U, Netzer CM, Netzer NC. J Travel Med; 2008 Feb; 15(5):307-14. PubMed ID: 19006503 [Abstract] [Full Text] [Related]
7. Intermittent altitude exposures reduce acute mountain sickness at 4300 m. Beidleman BA, Muza SR, Fulco CS, Cymerman A, Ditzler D, Stulz D, Staab JE, Skrinar GS, Lewis SF, Sawka MN. Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214 [Abstract] [Full Text] [Related]
8. Different duration of high-altitude pre-exposure associated with the incidence of acute mountain sickness on Jade Mountain. Weng YM, Chiu YH, Lynn JJ, Li WC, Wang SH, Kao WF, Hsu TY, Chiu TF, Lin YJ, Chan CW. Am J Emerg Med; 2013 Jul; 31(7):1113-7. PubMed ID: 23688567 [Abstract] [Full Text] [Related]
9. Short-term intermittent hypoxia reduces the severity of acute mountain sickness. Wille M, Gatterer H, Mairer K, Philippe M, Schwarzenbacher H, Faulhaber M, Burtscher M. Scand J Med Sci Sports; 2012 Oct; 22(5):e79-85. PubMed ID: 22853822 [Abstract] [Full Text] [Related]
10. Seven Passive 1-h Hypoxia Exposures Do Not Prevent AMS in Susceptible Individuals. Faulhaber M, Pocecco E, Gatterer H, Niedermeier M, Huth M, Dünnwald T, Menz V, Bernardi L, Burtscher M. Med Sci Sports Exerc; 2016 Dec; 48(12):2563-2570. PubMed ID: 27414687 [Abstract] [Full Text] [Related]
11. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM. Arch Intern Med; 2005 Feb 14; 165(3):296-301. PubMed ID: 15710792 [Abstract] [Full Text] [Related]
13. The effect of altitude pre-acclimatization on acute mountain sickness during reexposure. Lyons TP, Muza SR, Rock PB, Cymerman A. Aviat Space Environ Med; 1995 Oct 14; 66(10):957-62. PubMed ID: 8526832 [Abstract] [Full Text] [Related]
14. Respiratory alkalinization and posterior cerebral artery dilatation predict acute mountain sickness severity during 10 h normobaric hypoxia. Barclay H, Mukerji S, Kayser B, O'Donnell T, Tzeng YC, Hill S, Knapp K, Legg S, Frei D, Fan JL. Exp Physiol; 2021 Jan 14; 106(1):175-190. PubMed ID: 33347666 [Abstract] [Full Text] [Related]
15. Increased Cytokines at High Altitude: Lack of Effect of Ibuprofen on Acute Mountain Sickness, Physiological Variables, or Cytokine Levels. Lundeberg J, Feiner JR, Schober A, Sall JW, Eilers H, Bickler PE. High Alt Med Biol; 2018 Sep 14; 19(3):249-258. PubMed ID: 29924642 [Abstract] [Full Text] [Related]
16. Exercise intensity typical of mountain climbing does not exacerbate acute mountain sickness in normobaric hypoxia. Schommer K, Hammer M, Hotz L, Menold E, Bärtsch P, Berger MM. J Appl Physiol (1985); 2012 Oct 14; 113(7):1068-74. PubMed ID: 22858630 [Abstract] [Full Text] [Related]
17. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial. Basnyat B, Gertsch JH, Johnson EW, Castro-Marin F, Inoue Y, Yeh C. High Alt Med Biol; 2003 Oct 14; 4(1):45-52. PubMed ID: 12713711 [Abstract] [Full Text] [Related]
18. Symptom progression in acute mountain sickness during a 12-hour exposure to normobaric hypoxia equivalent to 4500 m. Burtscher M, Wille M, Menz V, Faulhaber M, Gatterer H. High Alt Med Biol; 2014 Dec 14; 15(4):446-51. PubMed ID: 25341048 [Abstract] [Full Text] [Related]
19. Ginkgo biloba does--and does not--prevent acute mountain sickness. Leadbetter G, Keyes LE, Maakestad KM, Olson S, Tissot van Patot MC, Hackett PH. Wilderness Environ Med; 2009 Dec 14; 20(1):66-71. PubMed ID: 19364166 [Abstract] [Full Text] [Related]
20. Exercise limitation of acetazolamide at altitude (3459 m). Bradwell AR, Myers SD, Beazley M, Ashdown K, Harris NG, Bradwell SB, Goodhart J, Imray CH, Wimalasena Y, Edsell ME, Pattinson KT, Wright AD, Harris SJ, Birmingham Medical Research Expeditionary Society. Wilderness Environ Med; 2014 Sep 14; 25(3):272-7. PubMed ID: 24931587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]